Skip to main content

RHUMBLINE ADVISERS

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$7,006,101
+$2,487,772 QoQ
Shares Held
404,743
+11.3% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 49% Shared 0% None 51%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. AMRX ranks #12 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,006,101 404,743
2026-03-31 $4,518,329 363,502
2025-12-31 $2,529,450 200,750
2025-09-30 $2,323,391 232,107
2025-06-30 $1,923,235 237,730
2025-03-31 $1,993,710 237,913
2024-12-31 $1,839,530 232,264
2024-09-30 $1,866,916 224,389
2024-06-30 $1,480,927 233,217
2024-03-31 $1,229,761 202,931
2023-12-31 $1,291,641 212,791
2023-09-30 $841,489 199,405
2023-06-30 $616,224 198,782
2023-03-31 $225,437 162,185
2022-12-31 $319,420 160,513
2022-09-30 $314,415 155,651
2022-06-30 $466,572 146,721
2022-03-31 $602,906 144,582
2021-12-31 $757,883 158,222
2021-09-30 $814,531 152,534
2021-06-30 $765,931 149,596
2021-03-31 $1,038,102 154,250
2020-12-31 $735,966 161,043
2020-09-30 $596,561 153,753
2020-06-30 $843,676 177,243
2020-03-31 $539,420 155,006